These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 15857986

  • 1. Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor.
    Kinomoto M, Yokoyama M, Sato H, Kojima A, Kurata T, Ikuta K, Sata T, Tokunaga K.
    J Virol; 2005 May; 79(10):5996-6004. PubMed ID: 15857986
    [Abstract] [Full Text] [Related]

  • 2. Mutations of conserved glycine residues within the membrane-spanning domain of human immunodeficiency virus type 1 gp41 can inhibit membrane fusion and incorporation of Env onto virions.
    Miyauchi K, Curran R, Matthews E, Komano J, Hoshino T, Engelman DM, Matsuda Z.
    Jpn J Infect Dis; 2006 Apr; 59(2):77-84. PubMed ID: 16632906
    [Abstract] [Full Text] [Related]

  • 3. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M, Lemay G, Cohen EA.
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [Abstract] [Full Text] [Related]

  • 4. The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120.
    Day JR, Van Damme N, Guatelli JC.
    Virology; 2006 Oct 25; 354(2):316-27. PubMed ID: 16905171
    [Abstract] [Full Text] [Related]

  • 5. Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction.
    Mo H, Konstantinidis AK, Stewart KD, Dekhtyar T, Ng T, Swift K, Matayoshi ED, Kati W, Kohlbrenner W, Molla A.
    Virology; 2004 Nov 24; 329(2):319-27. PubMed ID: 15518811
    [Abstract] [Full Text] [Related]

  • 6. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
    Deng Y, Zheng Q, Ketas TJ, Moore JP, Lu M.
    Biochemistry; 2007 Apr 10; 46(14):4360-9. PubMed ID: 17371053
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion.
    Miyauchi K, Komano J, Yokomaku Y, Sugiura W, Yamamoto N, Matsuda Z.
    J Virol; 2005 Apr 10; 79(8):4720-9. PubMed ID: 15795258
    [Abstract] [Full Text] [Related]

  • 9. Susceptibility to virus-cell fusion at the plasma membrane is reduced through expression of HIV gp41 cytoplasmic domains.
    Malinowsky K, Luksza J, Dittmar MT.
    Virology; 2008 Jun 20; 376(1):69-78. PubMed ID: 18400243
    [Abstract] [Full Text] [Related]

  • 10. The dominant-negative action of a fusion protein containing the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein gp41 in virus replication.
    Chan WE, Chen SS.
    J Biomed Sci; 2007 Nov 20; 14(6):717-29. PubMed ID: 17610148
    [Abstract] [Full Text] [Related]

  • 11. Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naïve Korean patients.
    Shin Y, Yoon CH, Yang HJ, Lim H, Choi BS, Kim SS, Kang C.
    Arch Virol; 2016 Jun 20; 161(6):1547-57. PubMed ID: 26997611
    [Abstract] [Full Text] [Related]

  • 12. X-ray crystallographic study of an HIV-1 fusion inhibitor with the gp41 S138A substitution.
    Watabe T, Terakawa Y, Watanabe K, Ohno H, Nakano H, Nakatsu T, Kato H, Izumi K, Kodama E, Matsuoka M, Kitaura K, Oishi S, Fujii N.
    J Mol Biol; 2009 Sep 25; 392(3):657-65. PubMed ID: 19616557
    [Abstract] [Full Text] [Related]

  • 13. Antiviral properties of two trimeric recombinant gp41 proteins.
    Delcroix-Genête D, Quan PL, Roger MG, Hazan U, Nisole S, Rousseau C.
    Retrovirology; 2006 Mar 03; 3():16. PubMed ID: 16515685
    [Abstract] [Full Text] [Related]

  • 14. Analysis of dominant-negative effects of mutant Env proteins of human immunodeficiency virus type 1.
    Iwatani Y, Kawano K, Ueno T, Tanaka M, Ishimoto A, Ito M, Sakai H.
    Virology; 2001 Jul 20; 286(1):45-53. PubMed ID: 11448157
    [Abstract] [Full Text] [Related]

  • 15. Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state.
    Sadler K, Zhang Y, Xu J, Yu Q, Tam JP.
    Biopolymers; 2008 Jul 20; 90(3):320-9. PubMed ID: 18338371
    [Abstract] [Full Text] [Related]

  • 16. The first B/G intersubtype recombinant form of human immunodeficiency virus type 1 (HIV-1) identified in Germany was undetected or underquantitated by some commercial viral load assays.
    von Truchsess I, Harris B, Schätzl HM, Hackett J.
    J Med Virol; 2006 Mar 20; 78(3):311-7. PubMed ID: 16419111
    [Abstract] [Full Text] [Related]

  • 17. The application of perfluorooctanoate to investigate trimerization of the human immunodeficiency virus-1 gp41 ectodomain by electrophoresis.
    Lin CH, Chang CC, Cheng SF, Chang DK.
    Electrophoresis; 2008 Aug 20; 29(15):3175-82. PubMed ID: 18633939
    [Abstract] [Full Text] [Related]

  • 18. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
    Affranchino JL, González SA.
    Virology; 2006 Mar 30; 347(1):217-25. PubMed ID: 16380144
    [Abstract] [Full Text] [Related]

  • 19. Structural characterization of the feline-immunodeficiency-virus envelope glycoprotein 36 ectodomain for the development of new antivirals.
    Desmaris F, Lemaire D, Ricard-Blum S, Chatrenet B, Forest E.
    Biochem J; 2005 Jul 15; 389(Pt 2):559-67. PubMed ID: 15799719
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells.
    Kinomoto M, Mukai T, Li YG, Iwabu Y, Warachit J, Palacios JA, Ibrahim MS, Tsuji S, Goto T, Ikuta K.
    Microbes Infect; 2004 Aug 15; 6(10):911-8. PubMed ID: 15310467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.